Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Techne Corp (TECH)  
$64.06 1.40 (2.23%) as of 4:30 Fri 4/26


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 157,280,000
Market Cap: 10.08(B)
Last Volume: 222,409 Avg Vol: 221,788
52 Week Range: $52.83 - $89.42
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P 400 MIDCAP
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Bio-Techne develops, manufactures and sells life science reagents, instruments and services for the research, diagnostics and bioprocessing markets. Co.'s Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics and cell and gene therapy. Co.'s Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 300
Total Buy Value $0 $0 $0 $105,765
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 10,400 10,400 90,722 101,476
Total Sell Value $800,627 $800,627 $7,896,377 $9,522,308
Total People Sold 1 1 2 4
Total Sell Transactions 1 1 3 7
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 411
  Page 3 of 17  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Kummeth Charles R. Chief Executive Officer   •       •      –    2022-08-07 4 D $382.97 $4,425,984 D/D (11,557) 240,403     -
   Kummeth Charles R. Chief Executive Officer   •       •      –    2022-08-07 4 OE $0.00 $0 D/D 16,918 251,960     -
   Hippel James Chief Financial Officer   •       •      –    2022-08-07 4 D $382.97 $742,196 D/D (1,938) 12,755     -
   Hippel James Chief Financial Officer   •       •      –    2022-08-07 4 OE $0.00 $0 D/D 3,938 14,693     -
   Kummeth Charles R. CHIEF EXECUTIVE OFFICER   •       •      –    2022-07-28 4 D $380.76 $10,549,717 D/D (27,707) 235,042     -
   Kummeth Charles R. CHIEF EXECUTIVE OFFICER   •       •      –    2022-07-28 4 OE $108.49 $4,919,588 D/D 45,346 262,749     -
   Kummeth Charles R. CHIEF EXECUTIVE OFFICER   •       •      –    2022-07-06 4 D $362.78 $11,222,599 D/D (30,935) 217,403     -
   Kummeth Charles R. CHIEF EXECUTIVE OFFICER   •       •      –    2022-07-06 4 OE $108.49 $5,424,500 D/D 50,000 248,338     -
   Baumgartner Robert V   –       •      –    2022-05-10 4 B $352.55 $105,765 D/D 300 10,106 0.01 -15%     
   Kelderman Kim Pres. Diagnostics & Genom   •       •      –    2022-02-08 4 OE $150.78 $299,901 D/D 1,989 1,989     -
   Geist William President, Protein Sciences   •       •      –    2022-02-01 4 A $0.00 $0 D/D 2,490 2,490     -
   Kummeth Charles R. Chief Executive Officer   •       •      –    2022-01-28 4 OE $106.59 $199,896 D/D 1,737 198,338     -
   Kelderman Kim Pres. Diagnostics & Genom   •       •      –    2021-11-19 4 S $503.76 $252,689 D/D (500) 0 14%     
   Kelderman Kim Pres. Diagnostics & Genom   •       •      –    2021-11-19 4 OE $150.78 $75,390 D/D 500 500     -
   Eansor N David President-Protein Sciences   •       –      –    2021-11-16 4 OE $125.05 $99,915 D/D 799 2,117     -
   Eansor N David President-Protein Sciences   •       –      –    2021-11-12 4 S $502.77 $13,688,193 D/D (27,159) 1,318 13%     
   Eansor N David President-Protein Sciences   •       –      –    2021-11-12 4 OE $125.05 $3,396,233 D/D 27,159 28,477     -
   Hippel James Chief Financial Officer   •       –      –    2021-11-02 4 AS $525.10 $105,020 D/D (200) 10,755 -16%     
   Hippel James Chief Financial Officer   •       –      –    2021-11-02 4 OE $125.05 $25,010 D/D 200 10,955     -
   Hippel James Chief Financial Officer   •       –      –    2021-11-01 4 AS $525.61 $4,644,970 D/D (8,822) 10,755 -23%     
   Hippel James Chief Financial Officer   •       –      –    2021-11-01 4 OE $125.05 $1,103,191 D/D 8,822 19,577     -
   Furlow Brenda S. SVP - General Counsel   •       •      –    2021-10-26 4 GA $0.00 $0 I/I 2,660 1,330     -
   Furlow Brenda S. SVP - General Counsel   •       •      –    2021-10-26 4 GD $0.00 $0 D/D 2,660 4,960     -
   Kelderman Kim Pres. Diagnostics & Genom   •       –      –    2021-09-22 4 AS $529.04 $434,871 D/D (822) 0 -22%     
   Steer Randolph C Director   –       •      –    2021-09-07 4 S $509.33 $4,079,823 D/D (8,000) 5,112 26%     
  411 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 17
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us